Inactive Instrument

DiaMonTech AG

Equities

Biotechnology & Medical Research

DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors

September 09, 2019

DiaMonTech GmbH announced that it has received more than €7 million in a round of funding led by new investor Bioventure Consulting GmbH on September 9, 2019. The transaction also included participation from two family offices as new investors and existing investor VC Fonds Technologie Berlin GmbH; a fund managed by IBB Beteiligungsgesellschaft mbH.

Latest news about DiaMonTech AG

DiaMonTech AG announced that it has received funding from Moll Family GmbH, and other investors	07/12	CI
DiaMonTech AG announced that it has received $5 million in funding from IBB Beteiligungsgesellschaft mbH, Unorthodox Ventures, Samsung Venture Investment Corporation	17/22/17	CI
DiaMonTech AG has withdrawn its IPO in the amount of €59.375 million.	26/19/26	CI
DAK-Gesundheit and DiaMonTech AG Plan Strategic Cooperation in the Non-Invasive Blood Glucose Monitoring Sector for New Treatment Strategies in the Diabetes Sector	25/19/25	CI
DiaMonTech AG has filed an IPO in the amount of €59.375 million.	13/19/13	CI
DiaMonTech AG Signs A Further Agreement with an International Sales Company	11/19/11	CI
DiaMonTech GmbH Publishes Results of Clinical Study Confirming the Accuracy of its Non-Invasive Blood Glucose-Monitoring Technology	21/19/21	CI
DiaMonTech GmbH Appoints Enrico Just as Managing Director and CFO	01/19/01	CI
Deutscher Apothekerverband e. V. & DiaMonTech GmbH Intends Strategic Cooperation to Significantly Improve the Care of Diabetes Patients and to Take an Innovative Step into the Future	16/19/16	CI
DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors	09/19/09	CI
DiaMonTech GmbH announced that it has received funding from IBB Beteiligungsgesellschaft mbH, Macnica, Inc., Jindong Investment Group Co., Ltd.	05/18/05	CI
DiaMonTech AG announced that it has received funding from Media Ventures GmbH	31/17/31	CI

Chart DiaMonTech AG

Duration

Period

More charts

Company Profile

DiaMonTech AG is a Germany-based medical device company. It develops a device for non-invasive measuring of glucose levels in diabetes patients. The device is based on spectroscopy and uses photothermal detection technology. The device range under development includes a desktop device for clinical settings and multiple users, as well as a compact pocket device for the end user.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Medical Devices

	1st Jan change	Capi.
MIMEDX GROUP, INC.	-22.92%	98Cr
NIBEC CO., LTD.	-14.04%	13Cr
COLLPLANT BIOTECHNOLOGIES LTD.	-21.75%	5.72Cr
KIM FOREST ENTERPRISE CO., LTD.	+2.03%	5.71Cr

Bio Medical Devices